More Than 10 Percent of World’s Population Is Obese, Study ...
A study in The New England Journal of Medicine showed problem had swept the globe, including regions that […]
A study in The New England Journal of Medicine showed problem had swept the globe, including regions that […]
People in transition because of layoffs, moves, illness or new ventures turned to Obamacare’s marketplaces as a stopgap, […]
Despite limited evidence to prove its drug works, the maker of Vivitrol has used political connections and marketing […]
The first-ever charges in America call attention to the practices of a small Muslim sect, and have women […]
The agency’s request about the drug, Opana ER, may signal a more aggressive approach against prescription opioids that […]
The report, published on Thursday by the Centers for Disease Control and Prevention, also provided for the first […]
The drug, Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they […]
The decision by the for-profit Blue Cross/Blue Shield to leave the Obamacare markets in 2018 will leave about […]
A New York Times analysis of insurance market data. Published: June 6, 2017 at 02:00AM from NYT Health […]
Like many doctors who prescribe opioids, Dr. Robert L. Wergin requires patients who receive these medications to sign […]
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)